Literature DB >> 27810413

Noncoding RNAs in the development, diagnosis, and prognosis of colorectal cancer.

Mingjiao Weng1, Di Wu2, Chao Yang1, Haisheng Peng3, Guangyu Wang4, Tianzhen Wang5, Xiaobo Li6.   

Abstract

More than 90% of the human genome is actively transcribed, but less than 2% of the total genome encodes protein-coding RNA, and thus, noncoding RNA (ncRNA) is a major component of the human transcriptome. Recently, ncRNA was demonstrated to play important roles in multiple biological processes by directly or indirectly interfering with gene expression, and the dysregulation of ncRNA is associated with a variety of diseases, including cancer. In this review, we summarize the function and mechanism of miRNA, long intergenic ncRNA, and some other types of ncRNAs, such as small nucleolar RNA, circular ncRNA, pseudogene RNA, and even protein-coding mRNA, in the progression of colorectal cancer (CRC). We also presented their clinical application in the diagnosis and prognosis of CRC. The summary of the current state of ncRNA in CRC will contribute to our understanding of the complex processes of CRC initiation and development and will help in the discovery of novel biomarkers and therapeutic targets for CRC diagnosis and treatment.
Copyright © 2016 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 27810413     DOI: 10.1016/j.trsl.2016.10.001

Source DB:  PubMed          Journal:  Transl Res        ISSN: 1878-1810            Impact factor:   7.012


  34 in total

1.  Long non-coding RNA bladder cancer-associated transcript 2 contributes to disease progression, chemoresistance and poor survival of patients with colorectal cancer.

Authors:  Yongjun Ren; Caixia Zhao; Yi He; Hao Xu; Xuli Min
Journal:  Oncol Lett       Date:  2019-06-18       Impact factor: 2.967

2.  Metastasis-associated lung adenocarcinoma transcript 1 regulates tumor progression: old wine in a new bottle.

Authors:  Xiaoyun He; Qijia Yan; Gaoyan Kuang; Yixuan Wang; Pengfei Cao; Chunlin Ou
Journal:  J Thorac Dis       Date:  2018-04       Impact factor: 2.895

Review 3.  Energy sensing pathways: Bridging type 2 diabetes and colorectal cancer?

Authors:  Juhong Yang; Reiko Nishihara; Xuehong Zhang; Shuji Ogino; Zhi Rong Qian
Journal:  J Diabetes Complications       Date:  2017-04-13       Impact factor: 2.852

4.  Constructed the ceRNA network and predicted a FEZF1-AS1/miR-92b-3p/ZIC5 axis in colon cancer.

Authors:  Xiaoping Yang; Pingfan Wu; Zirui Wang; Xiaolu Su; Zhiping Wu; Xueni Ma; Fanqi Wu; Dekui Zhang
Journal:  Mol Cell Biochem       Date:  2022-10-11       Impact factor: 3.842

5.  Deciphering the role of miR-187-3p/LRFN1 axis in modulating progression, aerobic glycolysis and immune microenvironment of clear cell renal cell carcinoma.

Authors:  Wenhao Xu; Wangrui Liu; Aihetaimujiang Anwaier; Xi Tian; Jiaqi Su; Guohai Shi; Shiyin Wei; Yuanyuan Qu; Hailiang Zhang; Dingwei Ye
Journal:  Discov Oncol       Date:  2022-07-07

Review 6.  Clinicopathological, genomic and immunological factors in colorectal cancer prognosis.

Authors:  K M Marks; N P West; E Morris; P Quirke
Journal:  Br J Surg       Date:  2018-01       Impact factor: 6.939

7.  Hepatitis B virus x protein induces epithelial-mesenchymal transition of hepatocellular carcinoma cells by regulating long non-coding RNA.

Authors:  Yinji Jin; Di Wu; Weiwei Yang; Mingjiao Weng; Yafei Li; Xuefei Wang; Xiao Zhang; Xiaoming Jin; Tianzhen Wang
Journal:  Virol J       Date:  2017-12-19       Impact factor: 4.099

8.  Diagnosis, prognosis and bioinformatics analysis of lncRNAs in hepatocellular carcinoma.

Authors:  Meiyu Dai; Siyuan Chen; Xiaomou Wei; Xuan Zhu; Fang Lan; Shengming Dai; Xue Qin
Journal:  Oncotarget       Date:  2017-09-28

9.  Knockdown of lncRNA-XIST enhances the chemosensitivity of NSCLC cells via suppression of autophagy.

Authors:  Wei Sun; Yukun Zu; Xiangning Fu; Yu Deng
Journal:  Oncol Rep       Date:  2017-10-24       Impact factor: 3.906

Review 10.  Potentials of Long Noncoding RNAs (LncRNAs) in Sarcoma: From Biomarkers to Therapeutic Targets.

Authors:  Li Min; Cassandra Garbutt; Chongqi Tu; Francis Hornicek; Zhenfeng Duan
Journal:  Int J Mol Sci       Date:  2017-03-29       Impact factor: 5.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.